Showing of 5 results
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in The Lancet presented at International Stroke Conference.
Harrington Discovery Institute Scholar Successfully Moves New Drug for Rare, Genetic Eye Disease into Clinical Trial
Richard Kramer, PhD, hopes to help patients with retinitis pigmentosa.
As many as eight in 10 people with Down syndrome develop Alzheimer’s disease; new study needs volunteers to help identify causes and treatments
Findings could potentially widen use for overweight adults who are high risk for heart disease.
New Technology Matching Patients Genomic Testing with Available Clinical Trials Nationwide Arrives at UH
Cleveland-based GenomOncology and UH Seidman Cancer Center enter into a market-leading partnership to increase clinical trial accrual rates.